Market Research Logo

genedrive plc (GDR) - Financial and Strategic SWOT Analysis Review

genedrive plc (GDR) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

genedrive plc (genedrive), formerly Epistem Holdings plc is a molecular diagnostics company. The company focuses on the development and commercialization of simple to use “point of need” system or point of care diagnostics platform for the diagnosis of infectious diseases and use in patient genotyping, pathogen detection and other indications. It also provides contract research services novel and transferable preclinical models and services to support decision making throughout the drug discovery and development pipeline to other pharmaceutical companies, as well as GCLP accredited gene expression and genotype analysis for drug development and diagnostic programs. genedrive is headquartered in Manchester, the UK.

genedrive plc Key Recent Developments

Nov 08,2017: Genedrive chief operating officer Allan Brown to step down
Nov 08,2017: genedrive: Directorate Change
Oct 17,2017: Genedrive Announces its audited Preliminary Results for the year ended 30 June 2017
Jul 27,2017: genedrive Awarded Additional $1.4m Funding by US Department of Defense to Continue Development of Genedrive as a Handheld Biohazard Identifier
Mar 30,2017: Genedrive: Interim Results for the six month period to 31 December 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
genedrive plc - Key Facts
genedrive plc - Key Employees
genedrive plc - Key Employee Biographies
genedrive plc - Major Products and Services
genedrive plc - History
genedrive plc - Company Statement
genedrive plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
genedrive plc - Business Description
genedrive plc - Corporate Strategy
genedrive plc - SWOT Analysis
SWOT Analysis - Overview
genedrive plc - Strengths
genedrive plc - Weaknesses
genedrive plc - Opportunities
genedrive plc - Threats
genedrive plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
genedrive plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
genedrive plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
genedrive plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 08, 2017: genedrive: Directorate Change
Oct 17, 2017: Genedrive Announces its audited Preliminary Results for the year ended 30 June 2017
Jul 27, 2017: genedrive Awarded Additional $1.4m Funding by US Department of Defense to Continue Development of Genedrive as a Handheld Biohazard Identifier
Mar 30, 2017: Genedrive: Interim Results for the six month period to 31 December 2016
Jan 16, 2017: genedrive Reports Delivery of Genedrive Units and Assays to the US Department of Defense in Programme to Develop a Handheld Biohazard Identifier
Nov 29, 2016: genedrive: Update on CFO Appointment
Oct 11, 2016: Genedrive Announces Preliminary Results for the year ended 30 June 2016
Sep 21, 2016: Genedrive Announces Appointment of Chief Financial Officer
Jul 25, 2016: Epistem Holdings Announces Re change of name, TIDM and website address
Jul 11, 2016: Epistem Holdings Announces Result of General Meeting and Change of Name
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
genedrive plc, Key Facts
genedrive plc, Key Employees
genedrive plc, Key Employee Biographies
genedrive plc, Major Products and Services
genedrive plc, History
genedrive plc, Subsidiaries
genedrive plc, Key Competitors
genedrive plc, Ratios based on current share price
genedrive plc, Annual Ratios
genedrive plc, Annual Ratios (Cont...1)
genedrive plc, Interim Ratios
genedrive plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
genedrive plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
genedrive plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
genedrive plc, Performance Chart (2013 - 2017)
genedrive plc, Ratio Charts
genedrive plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
genedrive plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report